MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) EV/FCF
As of 5 November 2026, MiniMed Group, Inc. (MMED) trades at a EV/FCF of −10.9×. Over the past ten years it has ranged from −14.4× (September 2026) to −5.5× (May 2026); the current reading is higher than 36% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | −6.4× | — |
| FY2025 | −10.6× | — |
| FY2024 | −10.6× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jul 2026 | −10.8× | — |
| Jan 2026 | −10.6× | — |
| Jul 2025 | −10.6× | — |
| Jan 2025 | −10.6× | — |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. compare | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| MMED MiniMed Group, Inc. | −10.9× |
| NVST Envista Holdings Corporation compare | 18.0× |
| MMSI Merit Medical Systems, Inc. compare | 24.7× |
| ICUI ICU Medical, Inc. compare | 25.5× |
| BLCO Bausch + Lomb Corporation compare | 51.6× |
| ATRC AtriCure, Inc. compare | 125× |
| TFX Teleflex Incorporated compare | 172× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement